Objective-To investigate the genetic contributions to the expression of cell surface adhesion molecules on endothelial cells (ECs) and to the release by ECs of chemokines, which are responsible for local inflammation. Methods and Results-Monocyte adhesion to ECs and transmigration across the endothelial barrier are the key steps in the formation of atherosclerotic plaques and the rupture of the existing plaques. Biopsy specimens were obtained from the femoral arteries of 131 pedigreed baboons (65 males and 66 females) aged 10.4Ϯ1.5 years (meanϮSD); arterial ECs were harvested and cultured up to the second passage and then subjected to in vitro challenge with tumor necrosis factor (TNF) ␣, 10 ng/mL, or vehicle for 4 hours. Endothelial surface adhesion molecules were measured using flow cytometry, and chemokines released by the ECs were measured by immunoassay. In response to TNF-␣ treatment, interleukin 8 and monocyte chemoattractant protein-1 released by ECs were increased 3.4-and 26-fold, respectively (PϽ0.001). 
I nflammatory processes play a key role in both the initiation and progression of atherosclerotic lesions. Acute inflammatory reactions are involved in plaque rupture, the ensuing thrombosis, and coronary artery occlusion, which account for most cases of acute coronary syndrome. A number of chemokines have been implicated in this inflammatory process. This reaction can be either a systemic response, detected by circulating levels of cytokines, or a local response, without detectable systemic changes. Because of limited access to key sites, such as the coronary arterial wall, localized inflammatory reactions are difficult to detect by current methods. Certain imaging technologies, such as intra-arterial ultrasonography and intra-arterial infrared in situ temperature measurements, have been used to detect localized inflammatory reactions; however, neither has been validated as a clinical tool. [1] [2] [3] Many hallmarks of chronic inflammation are associated with atherosclerotic plaques; these include recruitment of monocytes and T cells. Among reported cytokines/chemokines, monocyte chemoattractant protein-1 (MCP-1) and interleukin (IL) 8 are found in human atheroma and participate in atherogenesis. 4 -6 MCP-1 and IL-8 can each cause rolling monocytes to adhere firmly onto monolayers of endothelial cells (ECs) expressing E-selectin.
IL-8 was produced by macrophages that may be involved in the recruitment of inflammatory cells into atherosclerotic plaques. 7 MCP-1 is predominantly produced by macrophages and ECs and is a potent chemotactic factor for monocytes. 8 -10 MCP-1 contributes to macrophage infiltration and migration. 11 MCP-1 is 1 of the key factors that triggers the inflammatory process associated with atherogenesis. [12] [13] [14] Tumor necrosis factor (TNF) ␣ is an important mediator of cardiovascular disease, and it contributes to both myocardial dysfunction and vascular wall pathological features. [15] [16] [17] [18] In addition, TNF-␣ is associated with many-fold stimulations of IL-8 and MCP-1 expression. 19, 20 In addition to these endothelial-released chemokines, EC surface antigens, including CD62E (E-selectin), CD54 (intercellular adhesion molecule-1), and CD106 (vascular cell adhesion molecule-1), are also involved in the inflammatory cell adhesion process. [21] [22] [23] [24] [25] These cell surface adhesion molecules are expressed on endothelium in response to various cytokines (eg, TNF-␣) and are essential for the recruitment of leukocytes to the site of inflammation.
There is relatively little information regarding the genetic contributions to the inflammatory responses, either systemically or locally, in the arterial wall (where atherosclerosis occurs) that could account for the unknown genetic contributions to cardiovascular disease (CVD). Therefore, we hypothesize that responses to inflammatory stimulation in ECs vary from individual to individual, that there is a genetic basis to interindividual variation in responses, and that interindividual response variation is metabolically related to other biomarkers of atherogenesis and risk of CVD. In this study, we examined these hypotheses using cultured ECs derived from baboon femoral arteries, early passages of which reflect closely to their in vivo behaviors.
Methods

Animals
In total, 131 baboons (65 male and 66 female) were included in this study. The mean (SD) age of the baboons was 10.4 (1.5) years (range, 5.6 to 14.3 years). The mean (SD) body weight of these baboons was 23.4 (6.3) kg, and all were fed on a basal diet low in fat and cholesterol before a biopsy was performed of the femoral artery. Animal care and maintenance were performed by the veterinary resources staff of the Southwest National Primate Research Center at Southwest Foundation for Biomedical Research. This facility is certified by the Association for Assessment and Accreditation of Laboratory Animal Care International, and care giving practices conform to the Public Health Service Policy on Humane Care and Use of Laboratory Animals.
The baboons were members of a single 6-generation pedigree that includes 2426 individuals. This pedigree, with 384 founders, has resulted from managed breeding of olive baboons (Papio hamadryas anubis), yellow baboons (P h cynocephalus), and their hybrid progeny. The subset of 131 baboons used in the present study exhibited a rich array of relative pairs suitable for genetic analyses, among which were 44 pairs related at the level of half-siblings, 87 first cousins, 45 first cousins once removed, 61 second cousins, 133 second cousins once removed, and 123 third cousins.
EC Biopsy and Culture
ECs were isolated from baboon femoral arteries according to a method previously described. 26, 27 In brief, after baboons were anesthetized with ketamine, a biopsy specimen was obtained from a 1-to 3-cm length of femoral artery using standard surgical procedures by a trained veterinarian. The biopsy protocol is a survival procedure that was approved by the Institutional Animal Care and Use Committee of the Southwest Foundation for Biomedical Research. Baboons were released to their usual living environment 48 hours after their recovery. To collect ECs, the vessel was inflated with 0.1% collagenase (Invitrogen, Carlsbad, Calif), incubated at 37°C for 20 minutes, gently massaged to dislodge ECs, and then flushed with 1% FCS in PBS (Invitrogen). The released cells were collected by centrifugation at 300g for 10 minutes at 4°C and resuspended in culture media. The cells were seeded immediately on 6-well culture plates. The endothelial growth medium was composed of F-12K medium supplemented with FCS and growth factors, which is composed of the following: 500 mL of F-12K medium with glutamine (Invitrogen), 100 mL of FCS, 30 mg of endothelialderived growth factor (Sigma, St Louis, Mo), 50 mg of heparin, 1% Hepes (ϫ100; Invitrogen), 5 mL of insulin-transferin-selenium supplement (ϫ100; Invitrogen), and 1 mL of antibiotics (ϫ100; Invitrogen). When cultured cells reached confluence, they were detached using 0.05% trypsin solution (Invitrogen) and then seeded on 6-well plates for a second passage. After reaching confluence, the cells were again detached with trypsin and were frozen in liquid nitrogen at a density of approximately 10 6 cells per vial in 10% dimethyl sulfoxide in culture medium.
TNF-␣ Challenge In Vitro
The frozen ECs in a vial were thawed, seeded in a 6-well plate (approximately 150 000 cells per well), and grown to approximately 90% confluence by visual inspection; on average, it took 4 days (interquartile range, 3 to 5 days) to reach an average 90% confluence (interquartile range, 80% to 100% confluence). After exposing cells to 10 ng/mL of TNF-␣ (Sigma) or vehicle for 4 hours, culture medium was collected and stored at Ϫ80°C until analysis. The cells were then washed twice with PBS before lysing in hypotonic buffer (R&D Systems, Inc, Minneapolis, Minn). The lysate was subjected to centrifugation (1000 rpm for 10 minutes), and the supernatant was stored at Ϫ80°C until analysis.
Biochemical Measurements
IL-8 and MCP-1 in culture medium and soluble E-selectin (also, CD62E) in cell lysate were measured using sandwich-style enzymelinked immunoassay kits, as suggested by the manufacturer (R&D Systems, Inc). 26, 27 The proportions of cells expressing specific cellular adhesion molecules were quantified by standard immunofluorescence cell sorting techniques. 28 The specific antibodies used to detect the baboon proteins included anti-human CD62E (clone BBIG-E5; R&D Systems, Inc), anti-human CD54 (clone HA58; BD Biosciences, San Jose, Calif), and anti-human CD106 (clone 5K267; US Biological, Swampscott, Mass). Lysate protein concentrations were quantified using the bicinchoninic acid protein assay kit (Sigma).
Cholesterol concentrations were determined enzymatically using commercial reagents in a clinical chemistry analyzer. 29 Apolipoprotein B-containing lipoproteins were precipitated using heparinmanganese, and high-density lipoprotein (HDL) cholesterol was measured in the supernatant; low-density lipoprotein (LDL) cholesterol was calculated as the difference between total cholesterol and HDL cholesterol. Lipoprotein size properties were determined using gradient gel electrophoresis. 30 We used median diameters as global indicators of lipoprotein size distribution: HDL median diameter was defined as the diameter at which half the HDL absorbance (range, 8.2 to 24.0 nm) was on larger particles and half was on smaller particles; and LDL median diameter, the LDL interval (24 to 30 nm). C-reactive protein concentrations and total antioxidant status were determined using commercial reagents in a clinical chemistry analyzer. 31 
Statistical Analyses
Initial comparisons of the raw data were performed using paired t tests and commercially available software (Stata 9.2; StataCorp, College Station, Tex). However, because the animals that we studied come from the same pedigreed breeding colony, all other analyses used maximum likelihood estimation procedures implemented in a statistical genetic package (SOLAR), which are designed to account explicitly for nonindependence as the result of kinship. 32 We used likelihood ratio tests 33 to assess the significance of parameter estimates obtained using these procedures. Setting the false-positive rate at ␣ϭ0.05, we used a Bonferroni approach to correct for the effects of multiple testing. In this report, we characterize the results of our hypothesis tests as either "suggestive" (ie, nominally signif-icant [PϽ0.05]) or "significant" (ie, PϽ0.004 or PϽ0.001, depending on the number of tests).
Raw data were normalized by fitting to a gaussian curve and then standardized such that the mean and SD were 0 and 1, respectively. The statistical significance of the mean effects of covariates was assessed by adding each to the model, 1 by 1, and comparing the likelihood against a model without the covariate. In estimating heritability, we first adjusted each raw trait for a covariate set of age, sex, and body weight, regardless of their significance for that trait, and then normalized and standardized the covariate-adjusted residual before statistical genetic analysis. Heritability (h 2 ) was estimated as the proportion of residual variance explained by pedigree relationships (ie, h 2 ϭ 2 G / 2 P , where 2 G represents the additive genetic variance and 2 P the residual phenotypic variance); significance was assessed by comparison with a model in which heritability was fixed at 0. Simulations, using the same pedigree and data (ie, lysate protein levels) structure as in this study demonstrated we had 80% power to detect h 2 ϭ0.21 as significantly different from 0 (at ␣ϭ0.05) (M.C.M., unpublished data, 2010). Bivariate models were used to estimate correlation coefficients for the EC traits with various metabolic traits, and the significance of the correlation was assessed by comparison with a model in which the traits were forced to be uncorrelated.
Results
Inflammatory Responses of Baboon ECs to TNF-␣ Stimulation
When comparing with the cells treated by vehicle, TNF-␣ exposure resulted in 145-, 3.4-, and 26-fold increases in E-selectin, IL-8, and MCP-1, respectively (Table 1) ; these increases were highly significant by paired t test. However, lysate protein level, an indicator of cell number, did not differ by treatment, suggesting similar growth rates and confirming the comparability of the results across the parallel cultures for an animal in this experiment. In fact, raw lysate protein levels were strongly correlated within animal (r 2 ϭ0.99), suggesting that they reflect inherent characteristics of the sample. Regarding cell surface markers, a significantly higher percentage of TNF-␣-stimulated cells expressed CD62E, CD54, and CD106. Covariates, such as sex, age, and body weight, had relatively modest effects on these measures; a covariate was significant (after Bonferroni correction) in only 1 case (percentage CD54-positive cells after TNF-␣ stimulation).
Relationship of EC Phenotypes to In Vivo Metabolism
We also performed linear correlation coefficient analysis comparing the cultured EC phenotypes with several circulating cardiovascular risk factor variables representing lipoprotein metabolism and oxidative damage. As shown in Table 2 , several circulating metabolic traits were correlated with EC traits at the 0.05 level (suggestive correlations). However, after Bonferroni correction, we found only a few to be significant: negative correlations of cell number (ie, lysate protein level) with HDL cholesterol and LDL median diameter in both control and TNF-␣-stimulated cultures. Thus, it appears that aspects of EC phenotype are related to in vivo metabolic characteristics and that these relationships are maintained after 3 passages of in vitro culture.
Heritability in Endothelial Response to TNF-␣ Stimulation
We investigated genetic control of cultured EC phenotypes using maximum likelihood approaches implemented in SOLAR (Table 3) . We first adjusted the data for a constant set of covariates (ie, sex, age, and body weight) and then normalized and standardized the residual to better satisfy the underlying assumptions of the analyses. As indicated, the set of covariates accounted for only a modest proportion of total phenotypic variance, averaging 4%. Our estimates of the proportions of the residual phenotypic variance as the result of the additive effects of genes (heritability) for the 7 traits, measured under 2 conditions, ranged from 0% to 64%. Of the 12 nonzero heritability estimates, 7 were significant at the 0.05 level and 5 of these remained significant after Bonferroni correction for multiple testing (PՅ0.003). In fact, the estimated effect of genes on lysate protein variation was significant (PՅ0.001) in both treatments.
Discussion
Although inflammation is believed to participate in every stage of CVD, most of the evidence is based on systemic reactions. Yet, atherogenesis is a localized process in which site-specific inflammatory reactions, which are difficult to detect in vivo, may play a major role in determining the susceptibility to and the degree of injury by systemic risk factors, such as LDL or TNF-␣. 34 -36 This site-specific inflammatory response varies from subject to subject and undoubtedly reflects interindividual variation both in genes and responses to environment, with implications to atherogenesis. The use of cultured ECs to study these processes is supported by previous in vitro studies demonstrating close similarities with in vivo inflammatory responses to TNF-␣ stimulation. 37, 38 To our knowledge, this is the first study to demonstrate a statistically significant genetic contribution to any aspect of EC phenotype. If this is confirmed in human subjects, it could partly explain interindividual differences in inflammatory responses in the arterial wall that contribute to atherogenesis and plaque rupture. Our study shows that activation of ECs by TNF-␣ results in many-fold increases in the release of E-selectin, IL-8, MCP-1, and endothelial adhesion molecules (an endothelial response that is highly relevant to local vascular inflammation, thus plaque formation and rupture). Most important, the key finding in the current study is the significant heritability in the expression of endothelial adhesion molecules CD62E (E-selectin) and CD106 (vascular cell adhesion molecule-1) after TNF-␣ stimulation. Suggestive trends for heritability were also present for the levels of IL-8 and CD54 (intercellular adhesion molecule-1), which require confirmation in a larger sample. However, there is no statistical evidence for the heritability in the levels of soluble E-selectin and MCP-1 in the culture medium. Our findings suggest a strong genetic regulation in endothelial response to cytokine stimulation, thus susceptibility to atherogenesis and plaque stability.
Increased inflammatory activity may initiate the development of atherosclerosis and may cause the existing atherosclerotic plaque to become unstable and rupture. One of the key inflammatory activities in atherogenesis is the adhesion of monocytes and/or neutrophils. 39 Increased expression of EC surface adhesion molecules (eg, intercellular adhesion molecule-1 or vascular cell adhesion molecule-1), when stimulated by cytokines (eg, TNF-␣) is essential for this adhesion. After firm adhesion, these cells may transmigrate the endothelial monolayer to enter the subendothelial space (ie, the intima), where atherosclerotic accumulation is initiated. 34 Therefore, understanding the regulatory control of endothelial phenotypes is critical for the development of strategies aimed at controlling the inflammatory process in atherosclerosis.
Findings of significant heritability in some adhesion molecules or chemokines, but not the others, suggest the differ- IL indicates interleukin; MCP, monocyte chemoattractant protein; TNF, tumor necrosis factor. *Covariate (sex, age, and body weight) effects were assessed using raw traits, and heritability was assessed using covariate-adjusted data that were normalized and standardized. ential underlying regulatory mechanisms of different chemokines or differential sensitivities to the stimulus (ie, thresholds for response), which could be further confounded by potential experimental variations as the result of the choice of a single point (ie, 4 hours) after stimulation. However, these results will need to be confirmed in a planned expansion, involving approximately 350 animals. Our own simulation experiments (results not presented here) indicate that such an expanded sample from this specific population would potentially provide sufficient power for localization and identification, through linkage and pedigree-based association studies, of genes that are responsible and, ultimately, might lead to relevant diagnostics and therapeutics.
Perhaps the most intriguing finding of this study is the significant heritability of lysate protein levels and their significant correlations (ie, metabolic relationships) with other circulating CVD risk factors. Because the numbers of seeding cells were approximately the same in all samples and the duration of culture was similar, lysate protein level (an indicator of cell numbers in the culture) could be regarded as a crude estimator of the cell growth rate; however, we cannot exclude other explanations, such as heritable differences in susceptibility to apoptosis or in proportion of viable cells. Although the experiment was not specifically designed to study this aspect of EC phenotype, it appears that there is tremendous interindividual variation in the proliferative potential of these cells prepared from different baboons. Given the strong heritability, within-animal correlations, and significant correlations with other CVD risk factors, we speculate this variation of proliferative potential in culture reflects in vivo characteristics of the endothelium that could relate to intravascular repair capacity and risk of CVD. Future studies will incorporate a more reliable method of assessing cell growth potential to better characterize this novel finding.
Baboons exhibit atherosclerotic lesions, both naturally and experimentally, that resemble the early stages of human atherosclerosis. 40 Fatty streaks and fibromuscular plaques have been observed in vessels from a number of anatomical sites, including the iliac-femoral artery, 41 although it is likely that there was little atherosclerosis in these baboons fed a diet low in fat and cholesterol. Previous experiments indicated that, at least in some respects (eg, total antioxidant status), ECs from different anatomical sites in the vascular bed share similar characteristics 42 and that most of the functional features of femoral artery ECs are maintained through 4 passages. 26 Thus, this experimental protocol makes possible studies of atherosclerotic processes that are not practical to perform in humans.
In summary, for the first time to our knowledge, this study reports significant heritabilities of cell surface adhesion molecules in ECs when activated by TNF-␣. This finding suggests genetic regulation of key inflammatory processes that are responsible for initiation of atherosclerotic lesions and plaque rupture of existing atheroma. Further identification of the genes accounting for the heritability will be critically important in developing therapeutic strategies regulating this local inflammatory process and will facilitate development of diagnostic markers that can predict the inflammatory processes occurring in major arteries.
